Greece backs down on insulin prices
This article was originally published in Scrip
Executive Summary
The Greek government has backed down on its on average 25% price cuts for insulin products. This comes after Novo Nordisk's announcement last month that it would not sell its newer insulin products at the new prices, but would maintain their original higher prices instead; however there are now rumours that Novo Nordisk may face the state prosecutor for its actions.